{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:16:54Z","timestamp":1771305414315,"version":"3.50.1"},"reference-count":36,"publisher":"The Endocrine Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1210\/jc.2017-02078","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T13:55:02Z","timestamp":1520344502000},"page":"1005-1014","source":"Crossref","is-referenced-by-count":50,"title":["A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation"],"prefix":"10.1210","volume":"103","author":[{"given":"Iram","family":"Hussain","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedita","family":"Patni","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Ueda","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Sorkina","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre, Moscow, Russia"},{"name":"Laboratory of Molecular Endocrinology, Medical Scientific Educational Centre, Lomonosov Moscow State University, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M","family":"Valerio","sequence":"additional","affiliation":[{"name":"Division of Metabology, State Institute of Diabetes and Endocrinology, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Cochran","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Peeden","sequence":"additional","affiliation":[{"name":"East Tennessee Children\u2019s Hospital, University of Tennessee Department of Medicine, Knoxville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Tikhonovich","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoly","family":"Tiulpakov","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah R S","family":"Stender","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California San Francisco\u2013Fresno, Fresno, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Klouda","sequence":"additional","affiliation":[{"name":"University of Tennessee College of Medicine, Memphis, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwan K","family":"Tayeh","sequence":"additional","affiliation":[{"name":"Division of Pediatric Genetics, Metabolism and Genomic Medicine, Division of Genetics, Metabolism and Genomic Medicine and Department of Human Genetics, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W","family":"Innis","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priti","family":"Lal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelio F","family":"Godoy-Matos","sequence":"additional","affiliation":[{"name":"Division of Metabology, State Institute of Diabetes and Endocrinology, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena G","family":"Teles","sequence":"additional","affiliation":[{"name":"Monogenic Diabetes Group, Genetic Endocrinology Unit (LIM25), Hospital das Clinicas da Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley","family":"Adams-Huet","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J","family":"Rader","sequence":"additional","affiliation":[{"name":"Division of Translational Medicine and Human Genetics, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[{"name":"Department of Medicine, Western University, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif A","family":"Oral","sequence":"additional","affiliation":[{"name":"Metabolism, Endocrinology and Diabetes Division, Department of Internal of Medicine, Brehm Center for Diabetes, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhimanyu","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Nutrition and Metabolic Diseases, Department of Internal Medicine, Center for Human Nutrition, UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"issue":"4","key":"key\n\t\t\t\t20180307113512_B1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2005.10.018","article-title":"Laminopathies: multisystem dystrophy syndromes","volume":"87","author":"Jacob","year":"2006","journal-title":"Mol Genet Metab"},{"issue":"3","key":"key\n\t\t\t\t20180307113512_B2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1152\/physrev.00047.2005","article-title":"Nuclear lamins: laminopathies and their role in premature ageing","volume":"86","author":"Broers","year":"2006","journal-title":"Physiol Rev"},{"issue":"6937","key":"key\n\t\t\t\t20180307113512_B3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"issue":"6","key":"key\n\t\t\t\t20180307113512_B4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson\u2013Gilford progeria syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"key\n\t\t\t\t20180307113512_B5","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson\u2013Gilford progeria syndrome: review of the phenotype","volume":"140","author":"Hennekam","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"3","key":"key\n\t\t\t\t20180307113512_B6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20180307113512_B7","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1210\/jc.2009-0472","article-title":"Atypical progeroid syndrome due to heterozygous missense LMNA mutations","volume":"94","author":"Garg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180307113512_B8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nmd.2012.11.011","article-title":"Homozygous lamin A\/C familial lipodystrophy R482Q mutation in autosomal recessive Emery Dreifuss muscular dystrophy","volume":"23","author":"Wiltshire","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"key\n\t\t\t\t20180307113512_B9","first-page":"68","article-title":"Novel LMNA gene mutation in a patient with atypical Werner\u2019s syndrome","volume":"24","author":"Doh","year":"2009","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"issue":"12","key":"key\n\t\t\t\t20180307113512_B10","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1210\/jc.2005-0939","article-title":"Phenotypic heterogeneity in body fat distribution in patients with atypical Werner\u2019s syndrome due to heterozygous Arg133Leu lamin A\/C mutation","volume":"90","author":"Jacob","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20180307113512_B11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-12-0268","article-title":"Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations","volume":"167","author":"Mory","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key\n\t\t\t\t20180307113512_B12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1590\/S0004-27302008000800008","article-title":"Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation","volume":"52","author":"Mory","year":"2008","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"4","key":"key\n\t\t\t\t20180307113512_B13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jmg.2003.015651","article-title":"Novel lamin A\/C gene (LMNA) mutations in atypical progeroid syndromes","volume":"41","author":"Csoka","year":"2004","journal-title":"J Med Genet"},{"issue":"2","key":"key\n\t\t\t\t20180307113512_B14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.anpedi.2010.09.020","article-title":"[Difficult to manage diabetes mellitus associated with generalized congenital lipodystrophy. Report of two cases]","volume":"74","author":"Cardona-Hern\u00e1ndez","year":"2011","journal-title":"An Pediatr (Barc)"},{"issue":"6","key":"key\n\t\t\t\t20180307113512_B15","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1210\/jc.2002-021575","article-title":"Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy","volume":"88","author":"Simha","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20180307113512_B16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C","volume":"71","author":"Novelli","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"2","key":"key\n\t\t\t\t20180307113512_B17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"key\n\t\t\t\t20180307113512_B18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.26.1.30","article-title":"Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy","volume":"26","author":"Simha","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"key\n\t\t\t\t20180307113512_B19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/petr.12656","article-title":"Successful cardiac transplantation in a patient with congenital generalized lipodystrophy","volume":"20","author":"Marcos-Alonso","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"1","key":"key\n\t\t\t\t20180307113512_B20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jcem.87.1.8176","article-title":"Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy","volume":"87","author":"Bolan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20180307113512_B21","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20180307113512_B22","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2014-4491","article-title":"Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin","volume":"100","author":"Diker-Cohen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key\n\t\t\t\t20180307113512_B23","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1210\/jc.2015-2589","article-title":"A report of three cases with acquired generalized lipodystrophy with distinct autoimmune conditions treated with metreleptin","volume":"100","author":"Lebastchi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9382","key":"key\n\t\t\t\t20180307113512_B24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","article-title":"LMNA mutations in atypical Werner\u2019s syndrome","volume":"362","author":"Chen","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"key\n\t\t\t\t20180307113512_B25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"issue":"89","key":"key\n\t\t\t\t20180307113512_B26","doi-asserted-by":"crossref","first-page":"89ra58","DOI":"10.1126\/scitranslmed.3002346","article-title":"Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells","volume":"3","author":"Cao","year":"2011","journal-title":"Sci Transl Med"},{"issue":"12","key":"key\n\t\t\t\t20180307113512_B27","doi-asserted-by":"crossref","first-page":"e0168988","DOI":"10.1371\/journal.pone.0168988","article-title":"Temsirolimus partially rescues the Hutchinson\u2013Gilford progeria cellular phenotype","volume":"11","author":"Gabriel","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"key\n\t\t\t\t20180307113512_B28","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.celrep.2016.10.040","article-title":"Rapamycin reverses metabolic deficits in lamin A\/C-deficient mice","volume":"17","author":"Liao","year":"2016","journal-title":"Cell Reports"},{"issue":"12","key":"key\n\t\t\t\t20180307113512_B29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.4161\/cc.7.12.6157","article-title":"Leptin and mTOR: partners in metabolism and inflammation","volume":"7","author":"Maya-Monteiro","year":"2008","journal-title":"Cell Cycle"},{"issue":"48","key":"key\n\t\t\t\t20180307113512_B30","doi-asserted-by":"crossref","first-page":"19006","DOI":"10.1073\/pnas.0809743105","article-title":"Leptin-enhanced neointimal hyperplasia is reduced by mTOR and PI3K inhibitors","volume":"105","author":"Shan","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"key\n\t\t\t\t20180307113512_B31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.116.022188","article-title":"Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin, and zoledronic acid in children with Hutchinson\u2013Gilford progeria syndrome","volume":"134","author":"Gordon","year":"2016","journal-title":"Circulation"},{"issue":"41","key":"key\n\t\t\t\t20180307113512_B32","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1073\/pnas.1202529109","article-title":"Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson\u2013Gilford progeria syndrome","volume":"109","author":"Gordon","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"key\n\t\t\t\t20180307113512_B33","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1172\/JCI85908","article-title":"Modulation of LMNA splicing as a strategy to treat prelamin A diseases","volume":"126","author":"Lee","year":"2016","journal-title":"J Clin Invest"},{"issue":"6183","key":"key\n\t\t\t\t20180307113512_B34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1126\/science.1252651","article-title":"Chemical inhibition of NAT10 corrects defects of laminopathic cells","volume":"344","author":"Larrieu","year":"2014","journal-title":"Science"},{"issue":"6","key":"key\n\t\t\t\t20180307113512_B35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.stem.2011.04.019","article-title":"Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs","volume":"8","author":"Liu","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"6","key":"key\n\t\t\t\t20180307113512_B36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gt.2015.8","article-title":"Ameliorating pathogenesis by removing an exon containing a missense mutation: a potential exon-skipping therapy for laminopathies","volume":"22","author":"Scharner","year":"2015","journal-title":"Gene Ther"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/103\/3\/1005\/24262727\/jc.2017-02078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T12:08:25Z","timestamp":1520424505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/103\/3\/1005\/4743225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,12,15]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-02078","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,12,15]]}}}